What is he best known for?
The fields of study he is best known for:
His main research concerns NAD+ kinase, Biochemistry, AMPK, Sirtuin 1 and Internal medicine.
Biochemistry and Cell biology are frequently intertwined in his study.
His AMPK study combines topics from a wide range of disciplines, such as FOXO1, Neuroscience and Resveratrol.
His study focuses on the intersection of Sirtuin 1 and fields such as Mitochondrion with connections in the field of Energy homeostasis and Poly ADP ribose polymerase.
He has included themes like Metabolome, Endocrinology and SRT1720 in his Internal medicine study.
Carles Cantó combines subjects such as Mitochondrial biogenesis and Glucose homeostasis with his study of AMP-activated protein kinase.
His most cited work include:
- AMPK regulates energy expenditure by modulating NAD + metabolism and SIRT1 activity (2077 citations)
- PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. (931 citations)
- The NAD+ precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet induced obesity (642 citations)
What are the main themes of his work throughout his whole career to date?
Carles Cantó focuses on NAD+ kinase, Endocrinology, Internal medicine, Mitochondrion and Biochemistry.
He interconnects Sirtuin 1 and Metabolism in the investigation of issues within NAD+ kinase.
The various areas that Carles Cantó examines in his Endocrinology study include mitochondrial fusion and AMPK.
His AMPK research includes themes of FOXO1, Resveratrol and Longevity.
His work on Lipid metabolism, Carbohydrate metabolism and Glucose transporter as part of his general Internal medicine study is frequently connected to Energy source, thereby bridging the divide between different branches of science.
His Mitochondrion research is multidisciplinary, incorporating elements of Oxidative stress, Poly ADP ribose polymerase, Neuroscience and Homeostasis.
He most often published in these fields:
- NAD+ kinase (54.44%)
- Endocrinology (50.00%)
- Internal medicine (50.00%)
What were the highlights of his more recent work (between 2018-2021)?
- NAD+ kinase (54.44%)
- Nicotinamide riboside (26.67%)
- Mitochondrion (47.78%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are NAD+ kinase, Nicotinamide riboside, Mitochondrion, Cell biology and Model organism.
He has researched NAD+ kinase in several fields, including Endocrinology, Internal medicine, Homeostasis and Intracellular.
Much of his study explores Endocrinology relationship to Mitochondrial biogenesis.
Biochemistry and Enzyme are the main topics of his Nicotinamide riboside study.
His study on Progenitor cell, Stem cell and Endoplasmic reticulum is often connected to Asymmetric stem cell division as part of broader study in Cell biology.
As part of the same scientific family, Carles Cantó usually focuses on Model organism, concentrating on Type 2 diabetes and intersecting with Insulin resistance.
Between 2018 and 2021, his most popular works were:
- Deficient Endoplasmic Reticulum-Mitochondrial Phosphatidylserine Transfer Causes Liver Disease (74 citations)
- The NAD-Booster Nicotinamide Riboside Potently Stimulates Hematopoiesis through Increased Mitochondrial Clearance (56 citations)
- The NAD-Booster Nicotinamide Riboside Potently Stimulates Hematopoiesis through Increased Mitochondrial Clearance (56 citations)
In his most recent research, the most cited papers focused on:
His main research concerns Mitochondrion, Cell biology, Progenitor cell, Nicotinamide riboside and Asymmetric stem cell division.
Carles Cantó integrates Mitochondrion and Phosphatidylserine in his studies.
He integrates many fields, such as Phosphatidylserine and engineering, in his works.
MFN2 is closely attributed to Fatty liver in his work.
His Progenitor cell study incorporates themes from Transplantation and NAD+ kinase.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
